{
    "title": "Revance's Botox rival gets FDA approval for painful neck muscle condition",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12404975/Revances-Botox-rival-gets-FDA-approval-painful-neck-muscle-condition.html",
    "date": "2023-08-14",
    "keywords": [
        "company",
        "revance",
        "approval",
        "leo",
        "neck",
        "condition",
        "market",
        "dystonia",
        "group",
        "injection",
        "treatment",
        "botox",
        "daxxify",
        "health",
        "regulator",
        "use",
        "muscle",
        "food",
        "drug",
        "administration",
        "enter",
        "neuromodulator",
        "method",
        "contraction",
        "head",
        "side",
        "preview",
        "phase",
        "opinion",
        "decision",
        "faculty",
        "launch",
        "president",
        "dustin",
        "share",
        "information",
        "pricing",
        "product",
        "rival",
        "break",
        "marketing",
        "campaign",
        "quarter",
        "daxxifys",
        "duration",
        "effect",
        "latestage",
        "study",
        "fda",
        "antiwrinkle",
        "year",
        "reporting",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}